138 related articles for article (PubMed ID: 8839880)
1. Hydroxyurea therapy in highly unstable hemoglobin carriers.
Rose C; Bauters F; Galacteros F
Blood; 1996 Oct; 88(7):2807-8. PubMed ID: 8839880
[No Abstract] [Full Text] [Related]
2. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
3. [Clinical aspects, diagnosis and treatment of hereditary hemolytic anemia caused by carrier state of unstable hemoglobin].
Idel'son LI; Didkovskiĭ NA
Ter Arkh; 1976; 48(8):120-7. PubMed ID: 1024290
[No Abstract] [Full Text] [Related]
4. A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea?
Konstantopoulos K; Vagiopoulos G; Kantouni R; Lymperi S; Patriarcheas G; Georgakopoulos D; Fessas P
Haematologica; 1992; 77(4):352-4. PubMed ID: 1385278
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
Dean A; Wu YJ; Ley T; Fordis CM; Schechter AN
Prog Clin Biol Res; 1985; 191():205-16. PubMed ID: 2413473
[No Abstract] [Full Text] [Related]
6. Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/beta-thalassemia.
Rigano P; Manfré L; La Galla R; Renda D; Renda MC; Calabrese A; Calzolari R; Maggio A
Hemoglobin; 1997 May; 21(3):219-26. PubMed ID: 9140718
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic complication of splenectomy in unstable hemoglobin disorders: Hb Olmsted, Hb Koln.
Phyliky RL; Fairbanks VF
Am J Hematol; 1997 May; 55(1):53. PubMed ID: 9136923
[No Abstract] [Full Text] [Related]
8. Postsplenectomy erythrocytosis in hemoglobin Köln disease.
Egan EL; Fairbanks VF
N Engl J Med; 1973 May; 288(18):929-31. PubMed ID: 4693245
[No Abstract] [Full Text] [Related]
9. [Anomalous unstable hemoglobins, a special group of hereditary hemolytic anemias (survey of the literature and the authors' own data].
Didkovskiĭ NA; Filippova AV; Idel'son LI
Probl Gematol Pereliv Krovi; 1972 Nov; 17(11):38-46. PubMed ID: 4356586
[No Abstract] [Full Text] [Related]
10. Pharmacologic manipulation of fetal hemoglobin in the hemoglobinopathies.
Nathan DG
Ann N Y Acad Sci; 1990; 612():179-83. PubMed ID: 1705406
[No Abstract] [Full Text] [Related]
11. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter AN; Rodgers GP
Blood; 1996 Feb; 87(3):887-92. PubMed ID: 8562958
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea treatment in thalassaemia.
Konstantopoulos K; Lymperi S
Br J Haematol; 1998 Nov; 103(2):587. PubMed ID: 9827943
[No Abstract] [Full Text] [Related]
13. Pulmonary hypertension in a case of Hb-Mainz hemolytic anemia.
Lode HN; Krings G; Schulze-Neick I; Dähmlow S; Schroeder U; Bonnet R; DaPalma J; Luck W; Strauss G; Berger F; Gaedicke G
J Pediatr Hematol Oncol; 2007 Mar; 29(3):173-7. PubMed ID: 17356397
[TBL] [Abstract][Full Text] [Related]
14. Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.
Loovers HM; Tamminga N; Mulder AB; Tamminga RY
Hemoglobin; 2016 Sep; 40(5):341-344. PubMed ID: 27686852
[TBL] [Abstract][Full Text] [Related]
15. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
[No Abstract] [Full Text] [Related]
18. Regulation of fetal hemoglobin synthesis in the hemoglobinopathies.
Nathan DG
Ann N Y Acad Sci; 1985; 445():177-87. PubMed ID: 2409870
[No Abstract] [Full Text] [Related]
19. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
20. [Extramedullary hematopoiesis presenting as a chloroma in a patient known for abnormal hemoglobin (Geneva hemoglobin)].
Salathé C; Pugin P
Rev Med Suisse Romande; 2001 Aug; 121(8):585-7. PubMed ID: 11565221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
